Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment
Clinical trial NCT04263090 · COMPLETED
Trial details
- NCT number
- NCT04263090
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-29
- Primary completion
- 2023-12-20
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.